{"id":52291,"date":"2021-04-05T12:33:00","date_gmt":"2021-04-05T12:33:00","guid":{"rendered":"https:\/\/www.verificat.cat\/sputnik-v-work\/"},"modified":"2021-04-05T12:33:00","modified_gmt":"2021-04-05T12:33:00","slug":"sputnik-v-work","status":"publish","type":"post","link":"https:\/\/www.verificat.cat\/en\/sputnik-v-work\/","title":{"rendered":"Sputnik V"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>The Gamaleya National Research Center of Epidemiology and Microbiology has developed the Russian&rsquo;s <a href=\"https:\/\/sputnikvaccine.com\/about-us\/\" target=\"_blank\" rel=\"noopener\">Sputnik V<\/a> <a href=\"https:\/\/sputnikvaccine.com\/about-vaccine\/\" target=\"_blank\" rel=\"noopener\">viral vector<\/a> vaccine.&nbsp;This method uses a <a href=\"https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/viralvector.html\" target=\"_blank\" rel=\"noopener\">vector<\/a>, i.e. a different virus from SARS-CoV-2, to enter a cell and infect it. In this way, it uses the cellular machinery to produce the spike protein, present in this coronavirus, to generate antibodies.<\/p>\n<p>Russian President Vladimir Putin announced the <a href=\"https:\/\/www.bmj.com\/content\/372\/bmj.n743\" target=\"_blank\" rel=\"noopener\">approval of the formulation<\/a> in August 2020, when the phase III of the clinical trial had not yet begun. The <a href=\"https:\/\/sputnikvaccine.com\/newsroom\/pressreleases\/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d\/\" target=\"_blank\" rel=\"noopener\">results<\/a> of this phase, involving 40,000 people, were published on 24 November, promising <a href=\"https:\/\/sputnikvaccine.com\/newsroom\/pressreleases\/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d\/\" target=\"_blank\" rel=\"noopener\">91,4% efficacy<\/a> after <a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)00234-8\/fulltext\" target=\"_blank\" rel=\"noopener\">two doses 21 days apart<\/a>.&nbsp;<\/p>\n<p>Ninety-four percent of the volunteers reported <a href=\"https:\/\/www.bmj.com\/content\/372\/bmj.n743\" target=\"_blank\" rel=\"noopener\">very mild adverse effects<\/a>, although the Russian researchers have not detailed what these were. Sputnik V is currently being used in <a href=\"https:\/\/covid19.trackvaccines.org\/vaccines\/12\/\" target=\"_blank\" rel=\"noopener\">more than 50 countries<\/a>, including ten in Latin America and another ten in Africa.<\/p>\n<p>The <a href=\"https:\/\/sputnikvaccine.com\/about-vaccine\/\" target=\"_blank\" rel=\"noopener\">Sputnik V vaccine<\/a> can be stored at a temperature between 2&deg;C and 8&deg;C for <a href=\"https:\/\/tass.com\/society\/1252989\" target=\"_blank\" rel=\"noopener\">two months<\/a>.<\/p>\n<h3>Sputnik Light<\/h3>\n<p>Sputnik Light is the monodose version of the Russian vaccine Sputnik V, developed by the National Centre for Epidemiology and Microbiology Research Gamaleya, with which <a href=\"https:\/\/sputnikvaccine.com\/esp\/about-vaccine\/\" target=\"_blank\" rel=\"noopener\">only the first component of the vaccination is provided<\/a>. Clinical trials on this single injection have resulted in <a href=\"https:\/\/www.nature.com\/articles\/d41586-021-01813-2\" target=\"_blank\" rel=\"noopener\">an effectiveness of 79,4%<\/a> against symptomatic infection, according to the manufacturer&#39;s data.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Gamaleya National Research Center of Epidemiology and Microbiology has  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[169],"tags":[208],"class_list":["post-52291","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-vaccines-en","vc-legacy-post"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/comments?post=52291"}],"version-history":[{"count":0,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/media?parent=52291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/categories?post=52291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/tags?post=52291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}